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a  b  s  t  r  a  c  t
Zingiber  zerumbet  (L.) Roscoe  ex Sm.,  Zingiberaceae,  is a perennial,  aromatic  and  tuberose  plant  that
grows  in  humid  locations.  Also  known  as bitter  ginger,  Z.  zerumbet  is  traditionally  found  throughout  Asia,
where  it is widely  used  in foods,  beverages  and  for ornamental  purposes.  The  viscous  juice  present  in  the
inﬂorescence  of the plant  is  rich  in  surfactants  and  is also  known  as  “ginger  shampoo”.  The  rhizome  can
be  macerated  in ethanol  and  used  as  a tonic  and  a  stimulant.  In  Brazil  Z.  zerumbet  is  found  in the  Amazon
region,  in  Taruma-mirim  and Puraquequara  (rural areas  of  Manaus,  Amazon,  Brazil).  The main  chemical
compounds  found  in  Z.  zerumbet  are  terpenes  and polyphenols.  Zerumbone,  a  sesquiterpene,  is the  prin-
cipal  bioactive  compound  of  Z.  zerumbet  and  it is widely  studied  for its medicinal  properties.  The  extracts
and  isolated  metabolites  of  Z.  zerumbet  have  exhibited  the  following  properties:  anti-inﬂammatory,lavonoids
oxicity antioxidant,  antidiabetic,  anticancer,  antimicrobial,  analgesic  and antiviral.  The  National  Institute  of Ama-
zon  Research  in Brazil  is  currently  conducting  studies  using  extracts  from  this  plant  to  obtain  compounds
active  in  tumor  models.  The  aim  of  this  review  is to provide  a  overview  about  the  main  aspects  related
with  pharmacognosy  and  pharmacology  of  Z.  zerumbet  published  in  the literature  over  the  last  decade.
©  2016 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Zingiberaceae includes approximately 53 genera and more than
200 species, which are distributed across south and southeast Asia
Kress et al., 2002; Khatun et al., 2003). The members of this fam-
ly, such as Zingiber ofﬁcinale (ginger), Curcuma longa (turmeric),
ingiber zerumbet (bitter ginger) and Elettaria cardamomum (car-
amom), are used in folk medicine, agriculture, as food condiments,
nd for ornamental purposes (Filho et al., 2000; Jamal et al., 2006;
ndreo and Jorge, 2011).
The genus Zingiber contains approximately 85 species
Chaveerach et al., 2007). The main species of ginger consumed in
razil is Z. ofﬁcinale Roscoe, whose bioactive compounds gingerol,
hogaol and other gingerones confer its characteristic ﬂavor, aroma
nd anti-inﬂammatory properties. For these reasons it is mainly
sed in medicines and for culinary purposes (Elpo and Negrelle,
004; Andreo and Jorge, 2011). The city of Morretes in the state of
araná is the largest producer of ginger in Brazil (Elpo et al., 2008).
Z. zerumbet (L.) Roscoe ex Sm.  is widely cultivated in tropical and
ubtropical regions around the world (Baby et al., 2009; Al-Zubairi
t al., 2010; Eid et al., 2011). This species is traditionally known
s Asian ginger or bitter ginger. In Brazil, it is mainly found in the
∗ Corresponding author.
E-mail: airtonvp@uepg.br (A.V. Pereira).
http://dx.doi.org/10.1016/j.bjp.2016.01.006
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraregions of Taruamã-Mirim and Puraquequara, which are rural areas
of Manaus in the state of Amazonas.
The studies on chemical proﬁles of Z. ofﬁcinale and Z. zerumbet
has provided some differences between the two species. Limonene
occurs exclusively in Z. zerumbet, while citronellal is present only
in Z. ofﬁcinale (Jiang et al., 2006).
Interest in the therapeutic potential of Z. zerumbet has resulted
in several studies regarding its chemical composition. Research has
shown that bitter ginger yields a complex mixture of terpenes, with
a predominance of sesquiterpenes (Yu et al., 2008a).
From a commercial point of view, Z. zerumbet is a medicinal plant
with great potential for cultivation that does not require high costs.
In Brazil, the National Institute of Amazonian Research, in part-
nership with Biozer company, has developed products using bitter
ginger such as yogurt with a property that enhances the functions
of the gastrointestinal tract (Pinheiro and Castro, 2005).
Traditional uses
It is widely recognized that popular knowledge about the use
of medicinal plants in the treatment of several diseases needs to
be conﬁrmed. The traditional use of medicinal plants contributes
to the spread of this knowledge and serves as a basis for scientiﬁc
research seeking evidence of such pharmacological activities (Deb
et al., 2011).
 Ltda. All rights reserved.
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In Z. zerumbet the rhizome is the part that is most used for
edicinal purposes (Norulaini et al., 2009). These folk medicines
re generally prepared by maceration and infusion of fresh rhizome,
ut tinctures, poultices and even the plant in natura are other ther-
peutic uses (Tushar et al., 2010). Z. zerumbet has a wide spectrum
f traditional uses, as well as biological and pharmacological prop-
rties. The cone-shaped ﬂowers are long-lasting and are employed
n craft arrangements for ornamental purposes (Devi et al., 2014).
he rhizome is used as a tonic and as a stimulant (Sakinah et al.,
007). The rhizome serves as a seasoning in foods, while the ﬂoral
uds are consumed as vegetables (Sirirugsa, 1999).
The rhizome of ginger has been extensively used with remark-
ble therapeutic effects for the treatment of inﬂammation,
iarrhea, stomach cramps, bacterial infections, fever, ﬂatulence,
llergies and poisoning (Tewtrakul and Subhadhirasakul, 2007;
kamoto et al., 2011; Prakash et al., 2011b; Sidahmed et al., 2015).
owdered rhizome is used to treat ear infections, toothache and,
n the form of tea, to treat stomach disease (Ghosh et al., 2011).
he leaves are also used in therapies for joint pain. The juice
f cooked rhizome was reported to be effective in combating
orms in children (Somchit and Shukriyah, 2003; Ibrahim et al.,
007). The creamy substance present in the mature inﬂorescence,
s rich in surfactants and serves as a natural shampoo (Yu et al.,
008b).
otanical description
Z. zerumbet is a perennial tuberous plant that can be found nat-
rally as scattered plants in damp and shady parts of lowlands
r mountain slopes. It is often found near rivers, waterfalls and
ther water sources (Nalawade et al., 2003; Tzeng et al., 2013). This
pecies reproduces asexually by multiplying rhizome fragments
Kavitha and Thomas, 2008).
This plant is characterized by the presence of stems approxi-
ately 1–2 m tall, which are erect, oblique, round and covered by
heaths of ﬂat leaves. The leaves and inﬂorescences grow from a
hick rhizome or underground stem. The sheets are thin and are
pproximately 25–35 cm long, with a central raised midrib which
trongly raised on the lower surface. The sheets are arranged alter-
ately along the stem (Yob et al., 2011). The inﬂorescence, which is
reen when young, becomes red when old and reaches 6–12 cm in
eight. It is supported on a separate pseudostem from the leaves by
 narrow overlap that forms an open pouch, from which the ﬂowers
rise. An important botanical feature of Z. zerumbet is that the yarn
s connected to a long curved beak. The fruit is white, glabrous, thin-
alled and is approximately 1.5 cm long. The seeds are ellipsoids
nd black. The rhizome is perennial, thick, aromatic and yellow (Yob
t al., 2011).rmacognosia 26 (2016) 385–391
Chemical composition
Z. zerumbet is a rich source of different classes of compounds that
belong to a wide variety of chemical metabolites, such as polyphe-
nols, alkaloids and terpenes (Matthes et al., 1980; Jang et al., 2004;
Jang and Seo, 2005; Chung et al., 2007; Chang et al., 2012c).
Terpenes
Dev (1960) isolated zerumbone (1) from essential oil of Z.
zerumbet and determined its structure, while Ramaswami and
Bhattacharyya (1962) identiﬁed humulene monoxide and humu-
lene dioxide. Nigam and Levi (1963) studied the compounds
present in eight essential oil fractions and obtained borneol (2),
-pinene (3), camphor (4), linalool (5), zerumbone (1), limonene
(6), -humulene (7) and -caryophyllene (8).
Damodaran and Dev (1968a,b,c) characterized the following
sesquiterpenes: humulene epoxide I (9), II (10) and III (11), humu-
lenol I (12) and II (13) and caryophyllene oxide (14).
Dai et al. (2013) identiﬁed the presence of 46 compounds in the
essential oil extracted from the rhizome of Z. zerumbet. The most
abundant components were monoterpenes (76.1%): camphene (15)
(16.3%), sabinene (16) (14.6%), citral (17) (26.1%), zingiberene (18)
(7.2%) and lavandulyl acetate (19) (6.7%). In the aforementioned
study, the essential oil showed a low zerumbone content (1.2%).
Zerumbone (1) is a monocyclic sesquiterpene with three double
bonds, two  of which are coupled with carbonyl grouping and the
other is isolated (Songsiang et al., 2010; Kitayama, 2011; Kumar
et al., 2013). Rout et al. (2009) performed a quantitative analysis of
zerumbone in different parts of Z. zerumbet. The highest values were
found in the rhizome, followed by the roots. Bhuiyan et al. (2009)
evaluated the essential oil of Z. zerumbet using GC-MS and identiﬁed
the terpenes -pinene (3), camphor (4), linalool (5), zerumbone
(1), limonene (6), camphene (15), -caryophyllene, 3-carene (20),
4-terpineol (21) and eucalyptol (22).
Sulaiman et al. (2010) isolated and also quantiﬁed the com-
pounds present in the essential oil. The sesquiterpenes were
the major components, followed by monoterpenes. Zerumbone
(1) (36.12%) was the most abundant compound, followed by
humulene (10.03%). The following monoterpenes were identiﬁed
and quantiﬁed using GC–MS: borneol (2) (4.78%), -pinene (3)
(3.71%), camphor (4) (4.18%), linalool (5) (1.06%), camphene (15)
(14.29%), eucalyptol (22) (3.85%), -terpinene (23) (2.00%) and -
phellandrene (24) (1.63%).
Yu et al. (2008a) found that 85.81% of the compounds in the
essential oil were sesquiterpenes, conﬁrming the aforementioned
study. The oil was characterized by the presence of zerumbone
(1) (48.13%) and -humulene (7) (17.23%). Other sesquiterpenoids
were also isolated but in lower concentrations. Batubara et al.
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et, and obtained a yield of 0.12% of essential oil with characteristic
avor and color. The essential oil consisted of monoterpenes and
esquiterpenes. The authors found that the essential oil is rich in
erumbone (1) (11.05%), sabinene (16) (32.96%) and -myrcene
25) (13.27%).
olyphenols
Chien et al. (2008) isolated the following ﬂavonoids from
he rhizome of Z. zerumbet: 3-methyl kaempferol, kaempferol-3-
-(2,4-di-O-acetyl--l-rhamnopyranoside) (26) and kaempferol-
-O-(3,4-di-O-acetyl--l-rhamnopyranoside) (27). The phenolic
ompounds were extracted using ethyl acetate and identiﬁed by
PLC-DAD.
Ruslay et al. (2007) analyzed the composition of Z. zerum-
et extract and also isolated and identiﬁed some ﬂavonoids.
he compounds were kaempferol-3-O-rhamnoside (28),
aempferol-3-O-(2′′-O-acetyl)rhamnoside, kaempferol-3-O-(3′′-O-
cetyl)rhamnoside, kaempferol-3-O-(4′′-acetyl)rhamnoside (29),
aempferol-3-O-(3′′,4′′-diacetyl)rhamnoside (27) and kaempferol-
-O-(2′′,4′′-diacetyl)rhamnoside (26).
Similarly, Jang et al. (2004) studied the aromatic compounds
nd ﬂavonoids present in Z. zerumbet. The compounds that
ere isolated included: kaempferol-3,4′-O-dimethylether
30), kaempferol-3-O-methylether (31), kaempferol-3,4′,7-O-
rimethylether (32), 4′′-O-acetylafzelin (33), 2′′,4′′-O-diacety-
afzelin (34), 3′′,4′′-O-diacetylafzelin (35), kaempferol-3-O-(4-O-
cetyl--l-rhamnoside), kaempferol-3-O-(3,4-O-diacetyl--l-rha-
nopyranoside), kaempferol-3-O-(2,4-O-diacetyl--l-rhamnopy-
anoside).
The principal compounds found in Z. zerumbet are presented in
ox 1. According to Bhuiyan et al. (2009), the components present
n Z. zerumbet can vary according to the region where it is cultivated,
hich results in different percentages.harmacological activities
The therapeutic properties of the active compounds extracted
rom the rhizome have been used for treating stomach problems(Prakash et al., 2011a), and have been reported as having anti-
inﬂammatory (Murakami et al., 2002; Jalil et al., 2015), antitumoral
(Rashid and Pihie, 2005; Takada et al., 2005; Abdelwahab et al.,
2010), antioxidant (Ruslay et al., 2007; Rout et al., 2011), antibacte-
rial (Kumar et al., 2013), antiviral (Epstein–Barr virus) (Murakami
et al., 1999) and analgesic (Somchit et al., 2005) properties. The
health beneﬁts of Z. zerumbet have been described by many
authors. Pharmacological actions that highlight the properties of
pure zerumbone and rhizome extracts with different solvents are
presented in Box 2.
Z. zerumbet inhibits the activity of the enzyme cyclooxygen-
ase (COX) both in peripheral and central nervous system and the
synthesis of inﬂammatory mediators (Zakaria et al., 2010). Chien
et al. (2008) reported on the anti-inﬂammatory activity of iso-
lated compounds of Z. zerumbet in two  different models: paw
edema in mice, and cell cultures (macrophages). The treatment
of macrophages RAW 264.7 with zerumbone compounds and 3-
O-methyl-kaempferol presented the greatest suppression of the
production of inﬂammatory mediators (PGE2 and NO). Regarding
the animal experiments, zerumbone showed a lower increase in
paw volume when compared with indomethacin (positive control)
(38.8 ± 16.7 and 51.0 ± 16.7%, respectively).
Chaung et al. (2008) analyzed the aqueous extract of the rhizome
of Z. zerumbet to assess its anti-inﬂammatory activity in vitro and
in vivo. Intraperitoneal macrophages were obtained from BALB/c
mice and used to evaluate the production of TNF- (tumor necro-
sis factor) and IL-4 interleukins. The cells were stimulated with
lipopolysaccharide (LPS from Escherichia coli 0127: B8) and phor-
bol 12-myristate 13-acetate (PMA). Female speciﬁc-pathogen-free
ICR mice were used for in vivo assay. Anti-inﬂammatory activity
was evaluated after oral administration of extract at a dosage of
100 mg/kg per day for 28 days. Lung tissue was  taken and levels
of IL-1 were determined by ELISA kit. Hepatotoxicity was  eval-
uated at the concentrations of 0, 10, 100 and 1000 mg/kg per day
for 60 days. Treatment with 50–500 g/ml of the extract inhibited
the release of TNF- in peritoneal macrophages of 38 and 55%,
respectively. The lowest dose required to inhibit the production of
interleukin was  500 g/ml. The lung tissue of animals treated with
extract showed signiﬁcantly lower amounts of LTC4 than control
mice (429 ± 69 versus 261 ± 23 pg/lung). No differences in hepatic
388 A.Y. Koga et al. / Revista Brasileira de Farmacognosia 26 (2016) 385–391
Box  1
Reported principal compounds found in Zingiber zerumbet.
Class Sub-class Compounds References
Terpene
Sesquiterpenes Zerumbone (1), humulene (7), caryophyllene, zingiberene (18) Nakamura et al. (2004), Abdul et al.
(2008), Chung et al. (2008), Fakurazi
et al. (2008), Rout et al. (2009), Keong
et  al. (2010), Chang et al. (2012a) and
Rahman et al. (2013)
Monoterpenes Borneol (2), -pinene (3), linalool (5), limonene (6), camphene
(15),  sabinene (16), citral (17), -terpinene (23), eucalyptol (22),
-mircene
Hashemi et al. (2008), Rana et al.
(2008) and Dai et al. (2013)
Polyphenol Flavonoids Kaempferol, kaempferol-3-O-methyl;
Kaempferol-3-O-(2,4-di-O-acetyl--l-rhamnopyranoside) (26),
Kaempferol-3-O-(3,4-di-O-acetyl--l-rhamnopyranoside) (27),
Kaempferol-3-O-(4-acetyl)rhamnoside (29),
Kaempferol-3,4′ ,7-O-trimethylether
Masuda et al. (1991),  Nakatani et al.
(1991) and Chang et al. (2012c,d)
Box 2
Some pharmacological activities of Zingiber zerumbet.
Source Extract/active compound Biological activity Reference
Rhizome Methanol Anti-inﬂammatory and antinociceptive effects Zakaria et al. (2010)
Rhizome Chloroform Antimicrobial activity Phongpaichit et al. (2006)
Rhizome Chloroform Antimicrobial activity against methicillin-resistant S. aureus Voravuthikunchai et al. (2006)
Rhizome Ethanol Antimalarial activity Sriphana et al. (2013)
Rhizome Chloroform Activity against Epstein–Barr virus early antigen Vimala et al. (1999)
Commercial Zerumbone Antiproliferative and anti-inﬂammatory Effects Takada et al. (2005)
Rhizome Zerumbone Anti-inﬂammatory and anticarcinogenic activity Murakami et al. (2002)
Rhizome Zerumbone Activity against liver cancer Taha et al. (2010)
Rhizome Zerumbone Activity against ovarian and cervical cancer Abdelwahab et al. (2012)
Rhizome Diethyl ether Antitumor effects Huang et al. (2005)
Commercial Zerumbone Activity against breast cancer cells Sung et al. (2008)
Rhizome Ethyl acetate Nephroprotective effects Abdul Hamid et al. (2012)
Rhizome Ethanol Analgesic and anti-pyretic activities Somchit et al. (2005)
Rhizome Zerumbone Systemic antinociception Perimal et al. (2010)
Rhizome Water Aqueous extract are not acute toxic in concentrations of the test Hashemi et al. (2008)
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Rhizome Zerumbone Alzheimer’s disease
Commercial Zerumbone Inhibition of angiog
nzymes AST (aspartate transaminase) and ALT (alanine transami-
ase) were observed between negative control, parallel control and
queous extract groups.
Zakaria et al. (2011) reported on the anti-inﬂammatory activi-
ies of the essential oil of Z. zerumbet administered intraperitoneally
n male Sprague-Dawley rats. The paw edema test induced by car-
ageenan was used as a model of acute inﬂammation and the cotton
ellet-induced granuloma test was used for the chronic inﬂamma-
ion model. The inﬂammatory response induced by carrageenan
aw edema is considered COX-dependent, while the cotton pellet
odel showed antiproliferative activity against antitransudative
nd granulomatous edema.
Nag et al. (2013) evaluated the determination of total pheno-
ics (Folin Ciocalteu method), the ﬂavonoid content (complexation
ith aluminum chloride) and antioxidant activity (DPPH and
ydroxyl free radicals) of the ethanol extract of bitter ginger rhi-
ome. The results showed polyphenols of 33.64 ± 3.22 mg  (gallic
cid/g extract), ﬂavonoids of 26.79 ± 0.68 mg  (quercetin/g extract)
nd kaempferol 11.63 ± 0.09 mg/g extract. The antioxidant activ-
ty showed IC50 values of 417.14 (ascorbic acid: 2.71 g/ml)
nd 13.24 mg/ml  (quercetin: 2.46 g/ml) in tests with DPPH and
ydroxyl, respectively. Z. zerumbet demonstrated inhibition of
PPH in various concentrations; however, there are no other stud-
es in the literature using this radical in the evaluation of the
ntioxidant activity of this kind.
Hasham-hisam et al. (2011) screened samples of fresh ginger
hich were boiled for one hour and baked for 15 min. The extrac-
ion of oleoresin was performed using a Soxhlet extractor with
ifferent solvents and different extraction times. For the determi-
ation of antioxidant activity, the -carotene-linoleic acid assaySidahmed et al. (2015)
ent Bustamam et al. (2008)
 Park et al. (2015)
was used. The antioxidant activity of the extracts was compared
to that of butylated hydroxytoluene (BHT – positive control). The
combination of fresh sample with a polar solvent (acetone) with
12 h of extraction resulted in higher antioxidant activity.
Kader et al. (2011) studied the inhibition potential of extracts
from dried rhizomes. These extracts were used to determine
antimicrobial activity by being tested with ﬁve gram positive
(Bacillus cereus,  Bacillus megaterium, Bacillus subtilis,  Staphylococ-
cus aureus,  Sarcina lutea), eight gram negative (Escherichia coli,
Salmonella paratyphi, Salmonella typhi, Vibrio parahemolyticus, Vib-
rio mimicus, Shigella dysenteriae, Shigella boydii,  Pseudomonas aeru-
ginosa) and three pathogenic fungi (Candida albicans, Aspergillus
niger, Saccharomyces cerevisiae).  The ether and chloroform fractions
showed moderate activity against the bacteria and fungi that were
tested. The ethanol extract (400 mg/disk) showed the best antimi-
crobial activity against Vibrio parahaemolyticus (inhibition zone:
10 mm),  and all the tested fungi. The data showed the antimicrobial
and antifungal potential of the compounds present in Z. zerumbet
extracts.
Antitumor agents are known to interact with speciﬁc biologi-
cal molecules or pathways of cancer cells (Weijl et al., 1997). More
than sixty types of chemotherapeutic drugs used in cancer treat-
ment are molecules obtained from medicinal plants (Nadzri et al.,
2013). Recent studies have shown a signiﬁcant protective activity of
zerumbone in colon cancer (Yodkeeree et al., 2009); pancreas can-
cer (Shamoto et al., 2014); liver cancer (Alwi et al., 2007; Sakinah
et al., 2007; Taha et al., 2010); and leukemia (Xian et al., 2007;
Rahman et al., 2014).
Studies have demonstrated that zerumbone has little or no cyto-
toxic effect on normal human endothelial cells, dermal ﬁbroblasts
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ut induces apoptosis in many cancer cell lines. Zerumbone may
odulate a variety of molecular targets, both for the prevention of
nd for the treatment of cancer (Murakami et al., 2002; Xian et al.,
007; Prasannan et al., 2012).
Kim et al. (2009), isolated and puriﬁed the zerumbone com-
ound of the chloroform extract. In order to evaluate anticancer
ctivity, ICR mice have been used (rectal colon cancer assessment)
nd A/J (chemoprevention of lung cancer). The administration of
erumbone signiﬁcantly decreased mucosal inﬂammation in the
olon compared with the untreated group. Treatment with zerum-
one also affected the incidence of hyperplasia and adenoma in the
ungs, reducing the multiplicity of both.
The beneﬁt of Z. zerumbet regarding insulin sensitivity in
ructose-fed rats was studied by Chang et al. (2012c). Extraction
as carried out by maceration using hydroethanolic solution (95%,
/v) for seven days. Wistar rats were divided into two experimen-
al groups. The ﬁrst was chosen at random and received a diet to
nduce insulin resistance. The control group received a standard
iet. A group of animals fed with fructose was treated by oral gav-
ge with pioglitazone hydrochloride (hypoglycemic). Similarly to
ioglitazone, Z. zerumbet inhibits the glycation of hemoglobin and
romotes normoglycemia. These results show that the extract of
itter ginger can reverse the effects of hyperglycemia. The ability
o reverse insulin resistance may  be attributed to the presence of
ioactive compounds such as quercetin, curcumin and kaempferol.
Tzeng et al. (2013) conducted a study of the mechanism of
ction of the ethanolic extract of Z. zerumbet in its ability to attenu-
te streptozotocin-induced diabetic nephropathy. Bitter ginger can
romote glucose homeostasis and, therefore, it can be used as a
herapeutic to control diabetic complications. The ethanolic extract
95%) was prepared by the maceration method. Male Wistar rats
ere used in the experiments and diabetes was induced by inject-
ng streptozotocin (plasma glucose equal or higher than 350 mg/dl).
he urine of the animals was used to determine the concentra-
ions of albumin and creatinine. A reduction in body weight was
bserved during the experimental period. The other parameters,
uch as glycated hemoglobin fasting glucose, were reduced dur-
ng the eight weeks of treatment with Z. zerumbet when compared
ith the control group. The improved renal function during treat-
ent, and the volume of urine and excretion of proteins, was lower
han the group treated with vehicle only. The ginger extract and
etformin caused signiﬁcant improvements in the relative weight
f the kidneys, suggesting that both can reverse hypertrophy in
iabetic animals.
Analgesic activity can be associated with different mechanisms
f action, involving the release of inﬂammatory mediators, with
entral and peripheral action. Sulaiman et al. (2010) evaluated the
nalgesic activity of essential oil from Z. zerumbet in three different
odels: acetic acid-induced abdominal writhing, formalin and the
ot-plate tests. The acetic-acid writhing test was used to study the
eripheral nociception, while hot plate test to assess the central
nalgesia and formalin test evaluated both pathways. The essential
il administered intraperitoneally caused a dose-dependent inhi-
ition induced by acetic acid when compared to the control with
0.2% of inhibition for the dose of 300 mg/kg. This effect was also
bserved in the animals treated with acetylsalicylic acid. The results
f hot plate and formalin tests indicated that the anti-inﬂammatory
ction of essential oil of Z. zerumbet is mediated both centrally and
eripherally.
Khalid et al. (2011) studied the possible mechanisms involved
n antinociceptive activity. The essential oil of Z. zerumbet was
btained by hydrodistillation and for the experiments male ICR
ats were divided into groups. The antinociceptive activity was
erformed using the methods of writhing induced by acetic
cid, capsaicin-induced nociception, glutamate and phorbol 12-
yristate 13-acetate (PMA). Aspirin was used as a positive control.rmacognosia 26 (2016) 385–391 389
The results showed that the systemic administration of essential
oil of ginger caused a signiﬁcant dose-dependent inhibition in all
the models of nociception tests: writhing induced by acetic acid,
capsaicin, glutamate and PMA.
Chang et al. (2012b) evaluated the acute and chronic toxicity of
the ethanol extract of Z. zerumbet. The rhizome remained macera-
ted for seven days in ethanol. The phytochemical analysis showed
the presence of alkaloids, saponins, ﬂavonoids, lipids, polyphenols
and terpenoids. In vivo experiments using male rats were used and
aqueous solution was administered orally for fourteen days in the
acute toxicity test.
In the chronic toxicity test the concentrations used were 1000,
2000 and 3000 mg/kg extract administered by gavage, while the
control group received vehicle only for four weeks. The follow-
ing analyses were performed: hematological (red cells, white cells,
hemoglobin, hematocrit, mean corpuscular volume, mean corpus-
cular hemoglobin concentration, platelet count and volume of
platelets); biochemical (glucose, urea, creatinine, ALT, AST, total
cholesterol, triacylglyceride, HDL, LDL, gamma-GT, direct and indi-
rect bilirubin); and histopathological after the end of treatment.
There was  no evidence of toxicity and no changes in the hemato-
logical parameters were observed. There were also no changes in
weight and in the histological analysis of the tissue. Hematologi-
cal analysis is important for assessing the risk in humans. The data
obtained indicated that both the acute care and chronic care pro-
duced no clinical signs of change, death or toxicity in relation to the
doses used. This information can be useful for future studies of the
pharmacological potential of bitter ginger.
Discussion
Populations around the world use medicinal plants to treat
numerous diseases and ethnopharmacological information serves
as a starting point for developing new drugs.
Originating in India, Z. zerumbet has aroused the interest of
researchers due to its various applications. Currently, researchers
in the north of Brazil are studying the pharmacological activities
attributed to the bioactive compounds present in the rhizome. In
Brazil the National Institute of Amazonian Research has developed
important research regarding the biological activities of Z. zerumbet
to help to develop new drugs.
The evidence of the therapeutic properties of zerumbone from
bitter ginger, which are mainly secondary metabolites, is important
information that can help in the search to discover new drugs. From
a commercial point of view, a positive aspect is that ginger is easy
to cultivate and it has a lot of pharmacological properties.
The analysis of the literature presented in this study has great
relevance because several recent studies have demonstrated the
pharmacological activities of Z. zerumbet. The outcome of these
studies provides a view of the current state of research on the chem-
ical nature of the bioactive compounds and biological activities of
Z. zerumbet and will arouse the interest of many other researchers
to conduct further studies.
Based on numerous scientiﬁc references, Z. zerumbet is a plant
with high therapeutic potential. Further studies are required in
order to target the beneﬁts of its use as a medicinal plant and to
determine whether it can be a source of molecules that can serve
as a model for the discovery new drugs.
Final considerationsStudies of Z. zerumbet have shown the immense potential of
this medicinal plant in the treatment of various diseases. Its phyto-
chemical composition reveals that sesquiterpenes, monoterpenes
and phenolic compounds are the major compounds, and many of
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ts proven pharmacological properties are attributed to the main
esquiterpene, zerumbone. In Brazil, bitter ginger has been cul-
ivated in the Amazon and is spreading throughout the country.
ue to its numerous health beneﬁts, this ginger deserves special
ttention and greater diffusion of its culture as much as Z. ofﬁcinale
oscoe.
uthors’ contributions
AVP supervised and helped article writing, FLB was responsible
or review of article, and AYK (MSc student) was responsible for
ibliographic search.
onﬂicts of interest
The authors declare no conﬂicts of interest.
eferences
bdelwahab, S.I., Abdul, A.B., Zain, Z.N.M., Hadi, A.H.A., 2012. Zerumbone inhibits
interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical
cancer cells. Int. Immunopharmacol. 12, 594–602.
bdelwahab, S.I., Abdul, A.B., Devi, N., Taha, M.M.E., Al-Zubairi, A.S., Mohan, S., Mar-
iod, A.A., 2010. Regression of cervical intraepithelial neoplasia by zerumbone
in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of
mitochondria-regulated apoptosis. Exp. Toxicol. Pathol. 62, 461–469.
bdul, A.B.H., Al-zubairi, A.S., Tailan, N.D., Wahab, S.I.A., Zain, Z.N.M., Ruslay, S., Syam,
M.M., 2008. Anticancer activity of natural compound (zerumbone) extracted
from Zingiber zerumbet in human Hela cervical cancer cell. Int. J. Pharmacol. 4,
160–168.
bdul Hamid, Z., Budin, S.B., Jie, N.W., Hamid, A., Husain, K., Mohamed, J., 2012.
Nephroprotective effects of Zingiber zerumbet Smith ethyl acetate extract against
paracetamol-induced nephrotoxicity and oxidative stress in rats. Biomed.
Biotechnol. 13, 176–185.
l-Zubairi, A.S., Abdul, A.B., Yousif, M.,  Abdelwahab, S.I., Elhassan, M.M., Mohan, S.,
2010. In vivo and in vitro genotoxic effects of zerumbone. Caryologia 63, 11–17.
lwi, S.S.S., Nallappan, M.,  Pihie, A.H.L., 2007. Zerumbone exerts antiproliferative
activity via apoptosis on HepG2 cells. Malays. J. Biochem. Mol. Biol. 15, 19–23.
ndreo, D., Jorge, N., 2011. Capacidade antioxidante e estabilidade oxidativa de
Zingiber ofﬁcinale. Cient. Ciênc. Biol. Saúde 13, 33–37.
aby, S., Dan, M.,  Thaha, A.R.M., Johnson, A.J., Kurup, R., Balakrishnapillai, P., Lim,
C.K., 2009. High content of zerumbone in volatile oils of Zingiber zerumbet from
southern India and Malaysia. Flavour Frag. J. 24, 301–308.
atubara, I., Suparto, I.H., Sadiah, S., Matsuoka, R., Mitsunaga, T., 2013. Effect of
Zingiber zerumbet essential oils and zerumbone inhalation on body weight of
Sprague Dawley rat. Pak. J. Biol. Sci. 16, 1028–1033.
huiyan, M.N.I., Chowdhury, J.U., Begum, J., 2009. Chemical investigation of the
leaf  and rhizome essential oils of Zingiber zerumbet (L.) Smith from Bangladesh.
Bangladesh J. Pharmacol. 4, 9–12.
ustamam, A., Ibrahim, S., Al-zubairi, A.S., Met, M.,  Syam, M.M., 2008. Zerumbone:
a  natural compound with anti-cholinesterase activity. Am.  J. Pharm. Toxicol. 3,
209–211.
hang, C.J., Tzeng, T., Liou, S., Chang, Y., Liu, I., 2012a. Absence of genotoxic and
mutagenic effects of Zingiber zerumbet (L.) Smith (Zingiberaceae) extract. Evid.-
Based Compl. Alt., http://dx.doi.org/10.1155/2012/406296.
hang, C.J., Tzeng, T., Liou, S., Chang, Y., Liu, I., 2012b. Acute and 28-day subchronic
oral toxicity of an ethanol extract of Zingiber zerumbet (L.) Smith in rodents.
Evid.-Based Compl. Alt., http://dx.doi.org/10.1155/2012/608284.
hang, C.J., Tzeng, T., Chang, Y., Liu, I., 2012c. Beneﬁcial impact of Zingiber zerumbet
on  insulin sensitivity in fructose-fed rats. Planta Med. 78, 317–325.
hang, C.J., Tzeng, T., Liou, S., Chang, Y., Liu, I., 2012d. Regulation of lipid disorders
by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats. Food
Chem. 132, 460–467.
haung, H., Ho, C., Huang, T., 2008. Anti-hypersensitive and anti-inﬂammatory activ-
ities of water extract of Zingiber zerumbet (L.) Smith. Food Agric. Immunol. 19,
117–129.
haveerach, A., Mokkamul, P., Sudmoon, R., Tanee, T., 2007. A new species of Zingiber
(Zingiberaceae)  from northern Thailand. Taiwania 52, 159–163.
hien, T.Y., Chen, L.G., Lee, C.J., Lee, F.Y., Wang, C.C., 2008. Anti-inﬂammatory con-
stituents of Zingiber zerumbet. Food Chem. 110, 584–589.
hung, I., Kim, M.,  Park, W.,  Moon, H., 2008. Histone deacetylase inhibitors from the
rhizomes of Zingiber zerumbet. Pharmazie 63, 774–776.
hung, S.Y., Jang, D.S., Han, A., Jang, J.O., Kwon, Y., Seo, E., Lee, H.J., 2007. Modulation
of P-glycoprotein-mediated resistance by Kaempferol derivatives isolated from
Zingiber zerumbet. Phytother. Res. 21, 565–569.ai, D.N., Thang, T.D., Chau, T.M., Ogunwande, I.A., 2013. Chemical constituents of
the root essential oils of Zingiber rubens Roxb. and Zingiber zerumbet (L.) Smith.
Am.  J. Plant. Sci. 4, 7–10.
amodaran, N.P., Dev, S., 1968a. Studies in sesquiterpenes – XXXVIII. Structure of
humulene epoxide-I and humulene epoxide-II. Tetrahedron 24, 4123–4132.rmacognosia 26 (2016) 385–391
Damodaran, N.P., Dev, S., 1968b. Studies in sesquiterpenes – XXXVIII. Sesquiter-
penoids from the essential oil of Zingiber zerumbet Smith. Tetrahedron 24,
4113–4122.
Damodaran, N.P., Dev, S., 1968c. Studies in sesquiterpenes – XXXVIII. Structure of
humulenols. Tetrahedron 24, 4133–4142.
Deb, L., Singh, K.R., Singh, K.B., Thongam, B., 2011. Some ethno-medicinal plants used
by  the native practitioners of chandel district, Manipur, India. Int. Res. J. Pharm.
2,  199–200.
Dev, S., 1960. Studies in sesquiterpenes – XVI. Zerumbone, a monocyclic sesquiter-
pene ketone. Tetrahedron 8, 171–180.
Devi, N.B., Singh, P.K., Das, A.K., 2014. Ethnomedicinal utilization of Zingiberaceae in
the  valley districts of Manipur. J. Environ. Sci. Toxicol. Food Technol. 8, 21–23.
Eid, E.E.M., Abdul, A.B., Suliman, F.E.O., Sukari, M.A., Rasedee, A., Fatah, S.S., 2011.
Characterization of the inclusion complex of zerumbone with hydroxypropyl-
-cyclodextrin. Carbohydr. Polym. 83, 1707–1714.
Elpo, E.R.S., Negrelle, R.R.B., Rucker, N.G.A., 2008. Produc¸ão de gengibre no município
de  Morretes-PR. Sci. Agric. 9, 211–217.
Elpo, E.R.S., Negrelle, R.R.B., 2004. Zingiber ofﬁcinale Roscoe: aspectos botânicos e
ecológicos. Visão Acad. 5, 27–32.
Fakurazi, S., Hairuszah, I., Lip, J.M., Shanthi, G., 2008. The effect of pretreatment of
zerumbone on fatty liver following ethanol induced hepatotoxicity. J. Biol. Sci.
8,  1348–1351.
Filho, A.B.C., Souza, R.J., Braz, L.T., Tavares, M.,  2000. Cúrcuma: planta medicinal,
condimentar e de outros usos potenciais. Cienc. Rural 30, 171–175.
Ghosh, S., Majumder, P.B., Mandi, S.S., 2011. Species-speciﬁc aﬂp markers for identi-
ﬁcation of Z. ofﬁcinale, Z. montanum and Z. zerumbet (Zingiberaceae). Genet. Mol.
Res. 10, 218–229.
Hasham-hisam, R., Noor, N.M., Roslan, M.N., Sarmidi, M.R., Aziz, R.A., 2011. Opti-
mization of extraction conditions of antioxidant activity from Zingiber zerumbet
oleoresin. J. Appl. Sci. 11, 2394–2399.
Hashemi, S.R., Zulkiﬂi, I., Bejo, M.H., Farida, A., Somchit, M.N., 2008. Acute toxicity
study and phytochemical screening of selected herbal aqueous extract in broiler
chickens. Int. J. Pharmacol. 4, 352–360.
Huang, G., Chien, T., Chen, L., Wang, C., 2005. Antitumor effects of zerumbone from
Zingiber zerumbet in P-388D1 cells in vitro and in vivo. Planta Med. 71, 219–224.
Ibrahim, H., Khalid, N., Hussain, K., 2007. Cultivated ginger of Peninsular Malaysia:
utilization, proﬁles and micropropagation. Gard. Bull. Singap. 59, 71–88.
Jalil, M., Annuar, M.S.M., Tan, B.C., Khalid, N., 2015. Effects of selected physicochemi-
cal  parameters on zerumbone production of Zingiber zerumbet Smith cell suspen-
sion  culture. Evid.-Based Compl. Alt., http://dx.doi.org/10.1155/2015/757514.
Jamal, A., Javed, K., Aslam, M.,  Jafri, M.A., 2006. Gastroprotective effect of cardamom,
Elettaria cardamomum Maton. fruits in rats. J. Ethnopharmacol. 103, 149–153.
Jang, D.S., Seo, E., 2005. Potentially bioactive two new natural sesquiterpenoids from
the rhizomes of Zingiber zerumbet. Arch. Pharm. Res. 28, 294–296.
Jang, D.S., Han, A., Park, G., Jhon, G., Seo, E., 2004. Flavonoids and aromatic
compounds from the rhizomes of Zingiber zerumbet. Arch. Pharm. Res. 27,
386–389.
Jiang, H., Xie, Z., Koo, H.J., McLaughlin, S.P., Timmermann, B.N., Gang, D.R., 2006.
Metabolic proﬁling and phylogenetic analysis of medicinal Zingiber species:
tools for authentication of ginger (Zingiber Ofﬁcinale Rosc.). Phytochemistry 67,
1673–1685.
Kader, G., Nikkon, F., Rashid, M.A., Yeasmin, T., 2011. Antimicrobial activities of the
rhizome extract of Zingiber zerumbet Linn. Asian Pac. J. Trop. Biomed., 409–412.
Kavitha, P.G., Thomas, G., 2008. Population genetic structure of the clonal plant Zin-
giber zerumbet (L.) Smith (Zingiberaceae), a wild relative of cultivated ginger, and
its  response to pythium aphanidermatum. Euphytica 160, 89–100.
Keong, Y.S., Alitheen, N.B., Mustafa, S., Aziz, S.A., Rahman, M.A., Ali, A.M., 2010.
Immunomodulatory effects of zerumbone isolated from roots of Zingiber zerum-
bet.  J. Pharm. Sci. 23, 75–82.
Khalid, M.H., Akhtar, M.N., Mohamad, A.S., Perimal, E.K., Akira, A., Israf, D.A., Lajis,
N., Sulaiman, M.R., 2011. Antinociceptive effect of the essential oil of Zingiber
zerumbet in mice: possible mechanisms. J. Ethnopharmacol. 137, 345–351.
Khatun, A., Nasrin, S., Hossain, M.T., 2003. Large scale multiplication of ginger (Zin-
giber ofﬁcinale Rosc.) from shoot-tip culture. Online J. Biol. Sci. 3, 59–64.
Kim, M.,  Miyamoto, S., Yasui, Y., Oyama, T., Murakami, A., Tanaka, T., 2009. Zerum-
bone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in
mice. Int. J. Cancer 124, 264–271.
Kitayama, T., 2011. Attractive reactivity of a natural product, zerumbone. Biosci.
Biotechnol. Biochem. 75, 199–207.
Kress, W.J., Prince, L.M., Williams, K.J., 2002. The phylogeny and a new classiﬁcation
of  the gingers (Zingiberaceae): evidence from molecular data. Am.  J. Bot. 89,
1682–1696.
Kumar, S.C.S., Srinivas, P., Bettadaiah, B.K., 2013. Antibacterial and antimutagenic
activities of novel zerumbone analogues. Food Chem. 141, 1097–1103.
Masuda, T., Jitoe, A., Kato, S., Nakatani, N., 1991. Acetylated ﬂavonol glycosides from
Zingiber zerumbet. Phytochemistry 30, 2391–2392.
Matthes, H.W.D., Luu, B., Ourisson, G., 1980. Cytotoxic components of Zingiber zerum-
bet,  Curcuma zedoaria and C. domestica.  Phytochemistry 19, 2643–2650.
Murakami, A., Takahashi, M.,  Jiwajinda, S., Koshimizu, K., Ohigashi, H., 1999. Iden-
tiﬁcation of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of
12-o-tetradecanoylphorbol-13-acetate-induced Epstein-barr virus activation.
Biosci. Biotechnol. Biochem. 63, 1811–1812.
Murakami, A., Takahashi, D., Kinoshita, T., Koshimizu, K., Kim, H.W., Yoshihiro Naka-
mura, Y., Jiwajinda, S., Terao, J., Ohigashi, H., 2002. Zerumbone, a Southeast
Asian ginger sesquiterpene, markedly suppresses free radical generation, pro-
inﬂammatory protein production, and cancer cell proliferation accompanied by
 de Fa
N
N
N
N
N
N
N
O
P
P
P
P
P
P
P
R
R
R
R
R
R
R
R
SA.Y. Koga et al. / Revista Brasileira
apoptosis: the ,-unsaturated carbonyl group is a prerequisite. Carcinogenesis
23, 795–802.
adzri, N.M., Abdul, A.B., Sukari, M.A., Abdelwahab, S.I., Eid, E.E.M., Mohan, S.,
Kamalidehghan, B., Anasamy, T., Beng Ng, K., Syam, S., Arbab, I.A., Rahman,
H.S., Ali, H.M., 2013. Inclusion complex of zerumbone with hydroxypropyl--
cyclodextrin induces apoptosis in liver hepatocellular HepG2 cells via caspase
8/bid cleavage switch and modulating Bcl2/Bax ratio. Evid.-Based. Compl., 1–16.
ag, A., Bandyopadhyay, M.,  Mukherjee, A., 2013. Antioxidant activities and cyto-
toxicity of Zingiber zerumbet (L.) Smith rhizome. J. Pharmacogn. Phytochem. 2,
102–108.
akamura, Y., Yoshida, C., Murakami, A., Ohigashi, H., Osawa, T., Uchida, K., 2004.
Zerumbone, a tropical ginger sesquiterpene, activates phase II drug metabolizing
enzymes. FEBS Lett. 572, 245–250.
akatani, N., Jitoe, A., Masuda, T., Yonemori, S., 1991. Flavonoid constituents of
Zingiber zerumbet Smith. Agric. Biol. Chem. 55, 455–460.
alawade, S.M., Sagare, A.P., Lee, C., Kao, C., Tsay, H., 2003. Studies on tissue-culture
of  Chinese Medicinal plant resources in Taiwan and their sustainable utilization.
Bot.  Bull. Acad. Sin. 44, 79–98.
igam, I.C., Levi, L., 1963. Column and gas chromatographic analysis of oil of wild
ginger. Identiﬁcation and estimation of some new constituents. Can. J. Chem. 41,
1726–1730.
orulaini, N.A.N., Anuar, O., Omar, A.K.M., Alkarkhi, A.F.M., Setiano, W.B., Fate-
hah, M.O., Sahena, F., Zaidul, I.S.M., 2009. Optimization of SC–CO2 extraction
of  zerumbone from Zingiber zerumbet (L.) Smith. Food Chem. 114, 702–705.
kamoto, S., Yu, F., Harada, H., Okajima, T., Hattan, J., Misawa, N., Utsumi, R., 2011.
A short-chain dehydrogenase involved in terpene metabolism from Zingiber
zerumbet.  FASEB J. 278, 2892–2900.
ark, J., Park, G.M., Kim, J., 2015. Zerumbone, sesquiterpene photochemical from
ginger, inhibits angiogenesis. Korean J. Physiol. Pharmacol. 19, 335–340.
erimal, E.K., Akhtar, M.N., Mohamad, A.S., Khalid, M.H., Ming, O.H., Khalid, S.,
Tatt, L.M., Kamaldin, M.N., Zakaria, Z.A., Israf, D.A., Lajis, N., Sulaiman, M.R.,
2010. Zerumbone-induced antinociception: involvement of the l-arginine-
nitric oxide-cGMP-PKC-K+ ATP channel pathways. Basic Clin. Pharmacol. 108,
155–162.
hongpaichit, S., Vuddhakul, V., Subhadhirasakul Wattanapiromsakul, C., 2006.
Evaluation of the antimycobacterial activity of extracts from plants used as
self-medication by AIDS patients in Thailand. Pharm. Biol. 44, 71–75.
inheiro, C.C.S., Castro, J.G., 2005. Process for Obtaining Isolated Zerumbone from the
Roots of Zingiber zerumbet L. Case Smith (Zingiberaceae). INPA, PI 0505343-9.
rakash, R.O., Kumar, R.K., Rabinarayan, A., Kumar, M.S., 2011a. Pharmacognosti-
cal  and phytochemical studies of Zingiber zerumbet (L.) SM.  Rhizome Int. J. Res.
Ayurveda Pharm. 2, 698–703.
rakash, R.O., Rabinarayan, A., Kumar, M.S., 2011b. Zingiber zerumbet (L.) SM.  a reser-
voir  plant for therapeutic uses: a review. Int. J. Res. Ayurveda Pharm. 2, 1–23.
rasannan, R., Kalesh, K.A., Shamnungam, M.K., Nachiyappan, A., Ramachandran,
L.,  Nguyen, A.H., Kumar, A.P., Lakshamanan, M.,  Ahn, K.S., Sethi, G., 2012. Key
cell signaling pathways modulated by zerumbone: role in the prevention and
treatment of cancer. Biochem. Pharmacol. 84, 1268–1276.
ahman, H.S., Rasedee, A., Rasedee, A., How, C.W., Abdul, A.B., Zeenathul, N.A., Oth-
man, H.H., Saeed, M.I., Yeap, S.K., 2014. Zerumbone-loaded nanostructured lipid
carrier induces g2/m cell cycle arrest and apoptosis via mitochondrial pathway
in  a human lymphoblastic leukemia cell line. Int. J. Nanomed. 9, 527–538.
ahman, H.S., Rasedee, A., Rasedee, A., How, C.W., Abdul, A.B., Zeenathul, N.A., Oth-
man, H.H., Saeed, M.I., Yeap, S.K., 2013. Zerumbone-loaded nanostructured lipid
carriers: preparation, characterization, and antileukemic effect. Int. J. Nanomed.
8,  2769–2781.
amaswami, S.K., Bhattacharyya, S.C., 1962. Terpenoids – XXXI. Isolation of humu-
lene monoxide and humulene dioxide. Tetrahedron 18, 575–579.
ana, V.S., Verdeguer, M.,  Blazquez, M.A.A., 2008. Comparative study on the rhizomes
essential oil of three Zingiber species from Manipur. Indian Perfumer 52, 17–21.
ashid, R.A., Pihie, A.H.L., 2005. The antiproliferative effects of Zingiber zerumbet
extracts and fractions on the growth of human breast carcinoma cell lines.
Malays. J. Pharm. Sci. 3, 45–52.
out, K.K., Mishra, S.K., Sherma, J., 2009. Development and validation of an HPTLC
method for analysis of zerumbone, the anticancer marker from Zingiber zerum-
bet.  Acta. Chromatogr. 21, 443–452.
out, O.P., Acharya, R., Mishra, S.K., 2011. In vitro antioxidant potentials in leaves
of coleus aromaticus benth and rhizomes of Zingiber zerumbet (L.) Sm.  J. Appl.
Pharm. Sci. 1, 194–198.
uslay, S., Abas, F., Shaari, K., Zainal, Z., Maulidiani Sirat, H., Israf, D.A., Lajis,
N.H., 2007. Characterization of the components present in the active frac-
tions of health gingers (Curcuma xanthorrhiza and Zingiber zerumbet) by
HPLC–DAD–ESIIMS. Food Chem. 104, 1183–1191.
akinah, S., Handayani, S.T., Hawariah, A., 2007. Zerumbone induced apoptosis in
liver cancer cells via modulation of bax/bcl-2 ratio. Cancer Cell. Int. 7, 1–11.rmacognosia 26 (2016) 385–391 391
Shamoto, T., Matsuo Shibata, T., Tsuboi, K., Nagasaki, T., Takahashi, H.,  Funahashi,
H.,  Okada, Y., Takeyama, H., 2014. Zerumbone inhibits angiogenesis by blocking
NF-JB activity in pancreatic cancer. Pancreas J. 43, 396–404.
Sidahmed, H.M., Hashim, N.M., Abdulla, M.A., Ali, H.M., Mohan, S., Abdelwahab, S.I.,
Taha, M.M.,  Fai, L.M., Vadivelu, J., 2015. Antisecretory, gastroprotective, antiox-
idant and anti-helicobcter pylori activity of zerumbone from Zingiber zerumbet
(L.)  Smith. PLOS ONE, http://dx.doi.org/10.1371/journal.pone.0121060.
Sirirugsa, P., 1999. Thai Zingiberaceae: Species Diversity and their Uses.
IUPAC, http://www.iupac.org/symposia/proceedings/phuket97/sirirugsa.html
(accessed September 2014).
Somchit, M.N., Shukriyah, M.H.N., Bustamam, A.A., Zuraini, A., 2005. Anti-pyretic
and analgesic activity of Zingiber zerumbet. Int. J. Pharm. 1, 277–280.
Somchit, M.N., Shukriyah, A.H., 2003. Anti inﬂammatory property of ethanol and
water extracts of Zingiber zerumbet. Indian J. Pharmacol. 35, 181–182.
Songsiang, U., Pitchuanchom, S., Boonyarat, C., Hahnvajanawong, C., Yenjai, C., 2010.
Cytotoxicity against cholangiocarcinoma cell lines of Zerumbone derivatives.
Eur. J. Med. Chem. 45, 3794–3802.
Sriphana, U., Pitchuanchom, S., Kongsaeree, P., Yenjai, C., 2013. Antimalarial activity
and  cytotoxicity of zerumbone derivatives. Sci. Asia 39, 95–99.
Sulaiman, M.R., Mohamad, T.A.S.T., Mossadeq, W.M.S., Moin, S., Yusof, M., Mokhtar,
A.F., Zakaria, Z.A., Israf, D.A., Lajis, N., 2010. Antinociceptive activity of the essen-
tial  oil of Zingiber zerumbet. Planta Med. 76, 107–112.
Sung, B., Jhurani, S., Ahn, K.S., Mastuo, Y., Yi, T., Guha, S., Liu, M.,  Aggarwal, B.B.,
2008. Zerumbone down-regulates chemokine receptor CXCR4 expression lead-
ing  to inhibition of CXCL12-induced invasion of breast and pancreatic tumor
cells. Cancer. Res. 68, 8938–8944.
Taha, M.M.E., Abdul, A.B., Abdullah, R., Ibrahim, T.A.T., Abdelwahab, S.I., Mohan,
S.,  2010. Potential chemoprevention of diethylnitrosamine-initiated and 2-
acetylaminoﬂuorene-promoted hepatocarcinogenesis by zerumbone from the
rhizomes of the subtropical ginger (Zingiber zerumbet). Chem. Biol. Interact. 186,
295–305.
Takada, Y., Murakami, A., Aggarwal, B.B., 2005. Zerumbone abolishes NF-jB and
IjBa kinase activation leading to suppression of antiapoptotic and metastatic
gene expression, upregulation of apoptosis, and downregulation of invasion.
Oncogene 24, 6957–6969.
Tewtrakul, S., Subhadhirasakul, S., 2007. Anti-allergic activity of some selected
plants in the Zingiberaceae family. J. Ethnopharmacol. 109, 535–538.
Tushar, S.B., Sarma, G.C., Rangan, L., 2010. Ethnomedical uses of Zingiberaceous plants
of  Northeast India. J. Ethnopharmacol. 132, 286–296.
Tzeng, T., Liou, S., Chang, C.J., Liu, I., 2013. The ethanol extract of Zingiber zerumbet
attenuates streptozotocin-induced diabetic nephropathy in rats. Evid.-Based.
Compl., http://dx.doi.org/10.1155/2013/340645.
Vimala, S., Norhanom, A.W., Yadav, M.,  1999. Anti-tumour promoter activity in
Malaysian ginger rhizobia used in traditional medicine. Br. J. Cancer 80, 110–116.
Voravuthikunchai, S.P., Limsuwan, S., Supapol, O.,  Subhadhirasakul, S., 2006.
Antibacterial activity of extracts from family Zingiberaceae against foodborne
pathogens. J. Food. Safety. 26, 325–334.
Weijl, N.I., Cleton, F.J., Osanto, S., 1997. Free radicals and antioxidants in
chemotherapy-induced toxicity. Cancer Treat. Rev. 23, 209–240.
Xian, M., Ito, K., Nakazato, T., Shimizu, T., Chen, C., Yamato, K., Murakami, A., Ohi-
gashi, H., Ikeda, Y., Kizaki, M.,  2007. Zerumbone, a bioactive sesquiterpene,
induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and
mitochondria-mediated pathway. Cancer Sci. 98, 118–126.
Yob, N.J., Jofrry, M.,  Affandi, M.M.R., Teh, L.K., Salleh, M.Z., Zakaria, Z.A., 2011. Zingiber
zerumbet (L.) Smith: a review of its ethnomedicinal, chemical, and pharmaco-
logical uses. Evid.-Based. Compl., http://dx.doi.org/10.1155/2011/543216.
Yodkeeree, S., Sung, B., Limtrakul, P., Aggarwal, B.B., 2009. Zerumbone enhances
trail-induced apoptosis through the induction of death receptors in human colon
cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res.
69,  6581–6589.
Yu, F., Okamto, S., Nakasone, K., Adachi, K., Matsuda, S., Harada, H., Misawa, N.,
Utsumi, R., 2008a. Isolation and functional characterization of a -eudesmol
synthase, a new sesquiterpene synthase from Zingiber zerumbet Smith. FEBS
Lett. 582, 565–572.
Yu, F., Okamto, S., Nakasone, K., Adachi, K., Matsuda, S., Harada, H., Misawa, N.,
Utsumi, R., 2008b. Molecular cloning and functional characterization of -
humulene synthase, a possible key enzyme of zerumbone biosynthesis in
shampoo ginger (Zingiber zerumbet Smith). Planta 227, 1291–1299.
Zakaria, Z.A., Mohamad, A.S., Ahmad, M.S., Moktar, A.F., Israf, D.A., Lajis, N.H.,
Sulaiman, M.R., 2011. Preliminary analysis of the anti-inﬂammatory activity of
essential oils of Zingiber zerumbet. Biol. Res. Nurs. 13, 425–432.
Zakaria, Z.A., Mohamad, A.S., Chear, C.T., Wong, Y.Y., Israf, D.A., Sulaiman, M.R.,
2010. Antiinﬂammatory and antinociceptive activities of Zingiber zerumbet
methanol extract in experimental model systems. Med. Princ. Pract. 19,
287–294.
